65,437 trials
Major Depressive Disorder
Primary: Number of Participants With Emergence of Suicidal Ideation During Period II/III — 2 participants
Diabetes · Diabetes Mellitus, Type 1
Primary: Glycosylated Haemoglobin A1c (HbA1c) — 8.75; 8.64 Percent (%) glycosylated haemoglobin
Staphylococcal Skin Infection
Primary: Clinical Response — 323; 321; 52; 58 participants
Bacterial Pneumonia
Primary: Clinical Response — 214; 221; 46; 68 participants
Breast Cancer · Breast Neoplasms · Cancer of the Breast
Primary: Time to Disease Progression (Initial Treatment) — 9.28; 8.88 months — p=0.385
Alzheimer's Disease
Primary: Change From Baseline in Functional Linguistic Communication Inventory (FLCI) at Week 12 — -0.6; 0.7 Units on a scale — p=0.070
Mixed Dyslipidemia
Primary: Percentage of Subjects Reporting Adverse Events During Combination Therapy in the Preceding Double-Blind Studies or in the Preceding Open-Label Year 1 Study or in This…
Breast Neoplasms
Primary: Disease Free Survival (DFS): Number of Events (Disease Relapse or Death) From Baseline up to 2.75 Years — 352; 388 Events (disease relapse or death) — p=0.118
Type 2 Diabetes
Primary: Difference in Endogenous (Hepatic) Glucose Output During a High-dose Insulin Infusion From Baseline to After 12 Weeks of Treatment. — -0.06; -0.011; -0.01 mg/kg/min…
Abnormal Uterine Bleeding · Infertility
Primary: Percentage of Tissue Removed — 97.5 Percentage of tissue removed
HIV/AIDS
Primary: Area Under the Concentration-Time Curve(AUC) — 3.6; 3.4; 85.8; 79.2 hour*milligram/liter
Dental Plaque
Primary: Plaque Index — 3.31; 3.31; 2.91 Units on a scale — p=0.05
Gastroesophageal Reflux Disease
Primary: The Percentage of Heartburn-free Days (24-hour Periods) During the 6-month Maintenance Treatment Phase (ITT Population). — 82.58; 62.17 Percentage of Days — p=<0.0001
Gastroesophageal Reflux Disease
Primary: Treatment-emergent Adverse Events Experienced by >=5% of Patients in Any Treatment Group — 3; 2; 3; 2 Participants
Benign Prostatic Hyperplasia
Primary: Measuring Change From Baseline in International Prostate Symptom Score (IPSS) at 12 Weeks — 21.2; 21.2; -6.3; -3.4 Units on a scale